DC
LAB icon

Deere & Company’s Standard BioTools LAB Stock Holding History

Deere & Company’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-14,019
Closed -$618K – 992
2014
Q1 		$618K Sell
14,019
-6,321
-31% -$278K 0.04% 540
2013
Q4 		$779K Buy
+20,340
New +$599K 0.04% 500

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deere & Company's LAB Position: Q2 2014 in Review

Deere & Company sold out of Standard BioTools (LAB) in Q2 2014, closing a stake of 14,019 shares — an estimated $618K sold.

Deere & Company first reported a position in LAB in Q4 2013 and held it in 2 quarters. The position peaked at $779K in Q4 2013. 104 funds tracked by Wall St. Rank hold LAB as of Q2 2014.

  • Deere & Company reported no remaining Standard BioTools position as of Q2 2014 after selling out during the quarter.
  • Deere & Company sold 14,019 Standard BioTools shares in Q2 2014, an estimated $618K.
  • Deere & Company first reported a position in Standard BioTools in Q4 2013 and held it in 2 quarters.
  • Deere & Company's Standard BioTools position peaked at $779K in Q4 2013.
  • 104 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2014.

Based on Deere & Company's 13F filing for Q2 2014, filed 11 Aug 2014.